HIPAA Policy – DermatologyAlliance

Notice of Privacy Practices
This notice outlines how your medical information may be used and shared and how you can access this information. Please read it carefully.

Summary of Your Privacy Rights

We may use or share your health information for the following purposes:

  • Providing Care: To coordinate and manage your healthcare, including consultations and referrals between healthcare providers.
  • Processing Payments: To communicate with health plans, insurance providers, or workers’ compensation programs for billing and payment.
  • Informing You: To notify you about available health benefits and services or when prescriptions are ready for pickup.
  • Legal Requirements: To report abuse, neglect, or domestic violence to appropriate government authorities as required by law.
  • Family and Caregiver Communication: Share relevant information with individuals you designate, such as family members, friends, or caregivers.

We may also use your health information for:

  • Business Associates: To maintain secure record-keeping through contracted entities.
  • Healthcare Operations: To improve quality of care and for public safety purposes.
  • Health Oversight Activities: To comply with regulations from federal or state agencies overseeing our operations.
  • Legal and Security Reasons: For lawful purposes such as military and national security, legal proceedings, subpoenas, or discovery requests.
  • Organ and Tissue Donation Requests: To assist in organ or tissue donation programs.
  • Data Breach Notifications: To notify you of any breaches involving your protected health information.
  • Law Enforcement Purposes: When required by law or for investigations.
  • Coroner, Medical Examiner, or Funeral Director Uses: For death investigations or related duties.
  • FDA Reporting: To report adverse events as required.
  • Controlled Substance Reporting: To meet legal requirements, including timely reporting to the Department of Justice for controlled substances.

Your Rights

You have the right to:

  • Inspect and obtain a copy of this Notice at any time.
  • Request restrictions on how your health information is used or disclosed.
  • Request confidential communication of your health information.
  • Access, amend, and obtain copies of your protected health information.
  • Receive a record of disclosures made about your health information.
  • Be informed if your protected health information is affected by a data breach.

Suppose you believe your rights have been violated. In that case, you can file a written complaint without fear of retaliation with either DermatologyAlliance’s Compliance Officer or the U.S. Department of Health and Human Services.

Our Responsibilities

DermatologyAlliance is required to:

  • Keep your health information private and secure.
  • Use or disclose your health information only as permitted by this Notice or as authorized by you.
  • Obtain your explicit written authorization for uses not covered by this Notice, including marketing purposes, selling health information, or other unauthorized disclosures.
  • Inform you of updates or changes to this Notice as necessary.

Acknowledgment

By receiving this Notice, you acknowledge that you have been informed of your rights. This Notice is available upon request. DermatologyAlliance reserves the right to revise the terms of this Notice at any time, and you will be informed of any significant updates.

Contact Information

For further details or to file a complaint, please contact:
DermatologyAlliance Compliance Officer
12469 Timberland Blvd, Suite 501, Fort Worth, TX 76244
817-431-6555
info@dermatologyalliancetx.com

Effective Date: 01/20/2025

BOOK AN APPOINTMENT

VISIT OUR OTHER LOCATIONS

KELLER LOCATION

12469 Timberland Blvd #501
Fort Worth, TX 76244

Fax: 817.431.7979

817-431-6555

COPPELL LOCATION

215 South Denton Tap Rd Suite 170 Coppell, TX 75019

Fax: 972.304.6050

469-312-7302

ROANOKE LOCATION

206 Denton Dr
Roanoke, TX 76262

Fax: 682.237.2274

682-237-2271

SPECIAL OFFERS

We accept several insurance providers. Check out the complete list to see if you are covered.

Safety Information

Critical Details About Compounded Semaglutide

Compounded medications are legally allowed to be prescribed under federal law; however, they are not FDA-approved and do not undergo FDA evaluation for safety, efficacy, or production standards. At DermatologyAlliance, compounded semaglutide is prescribed based on an individualized medical assessment.

WARNING: Potential Risk of Thyroid C-Cell Tumors
Research in animals has linked semaglutide, the active ingredient in some GLP-1 receptor agonists, to thyroid tumors, including medullary thyroid carcinoma (MTC). It is unclear if semaglutide causes similar tumors in humans. Notify your healthcare provider immediately if you notice symptoms of thyroid cancer, such as neck lumps or swelling, hoarseness, swallowing difficulties, or shortness of breath. Compounded semaglutide is not suitable for individuals with personal or family histories of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Uses of Compounded Semaglutide
Compounded semaglutide is intended for use alongside a reduced-calorie diet and increased physical activity to manage chronic weight in adults who meet the following criteria:

  • A body mass index (BMI) of 30 kg/m² or higher (classified as obesity), or
  • A BMI of 27 kg/m² or higher (overweight) with at least one weight-related condition, such as type 2 diabetes, hypertension, or abnormal cholesterol levels.

Usage Restrictions

  • Do not use compounded semaglutide in combination with other GLP-1 receptor agonists or semaglutide-containing products.
  • Its safety and effectiveness when combined with other weight management medications have not been established.
  • Patients with a history of pancreatitis or gastroparesis have not been studied for this treatment.

Avoid Use If You:

  • Have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
  • Are diagnosed with type 1 diabetes, pancreatitis, or gastroparesis.
  • Are allergic to semaglutide or any inactive ingredients.
  • Have a history of suicidal thoughts or behavior.

Precautions and Warnings:

  • Acute Pancreatitis: Stop using the medication if pancreatitis is suspected.
  • Gallbladder Issues: Monitor for symptoms of gallbladder disease, including gallstones, and seek medical advice as needed.
  • Low Blood Sugar: When combined with insulin or similar medications, there is an increased risk of hypoglycemia. Regularly monitor blood sugar and adjust doses as recommended by your provider.
  • Kidney Health: Monitor kidney function, particularly in patients with renal impairment or those experiencing severe gastrointestinal effects.
  • Mental Health Concerns: Watch for mood changes, depression, or suicidal thoughts, and discontinue use if these symptoms occur.

Pregnancy and Fertility Considerations
Semaglutide may harm an unborn child. Avoid use during pregnancy or if planning to become pregnant. Stop treatment at least two months before attempting to conceive.

Common Side Effects:
Frequently reported side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, headaches, and low blood sugar in patients with type 2 diabetes.

Potential Drug Interactions:
Compounded semaglutide slows gastric emptying, which could impact the absorption of oral medications. Consult your healthcare provider to manage potential interactions effectively.

Medication Disclaimer

Essential Information on Medications: Saxenda®, Victoza®, Wegovy®, and Ozempic® are patented products of Novo Nordisk™, while Eli Lilly and Company™ produce Mounjaro™ and Zepbound. This website is not affiliated with, endorsed by, or connected to these companies or their products in any capacity. While these FDA-approved medications may be available through other sources, we do not provide them, and they are currently experiencing supply shortages. During such shortages, pharmacies might prepare compounded versions of these drugs, provided they comply with the Federal Food, Drug, and Cosmetic Act’s requirements. Compounded medications are valuable for patients with unique medical needs that FDA-approved drugs cannot address. However, it is important to note that compounded drugs are not FDA-approved, nor do they undergo premarketing evaluations for safety, effectiveness, or quality. The FDA has not assessed these medications for their intended uses, nor has the manufacturing process for compounded drugs been reviewed by the FDA.